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Compelling evidence indicates that the CRISPR-Cas
system protects prokaryotes from viruses and other
potential genome invaders. This adaptive prokaryotic
immunesystemarises from theclustered regularly in-
terspaced short palindromic repeats (CRISPRs)
found in prokaryotic genomes, which harbor short
invader-derived sequences, and theCRISPR-associ-
ated (Cas) protein-coding genes. Here, we have
identified a CRISPR-Cas effector complex that is
comprised of small invader-targeting RNAs from the
CRISPR loci (termed prokaryotic silencing (psi)RNAs)
and the RAMP module (or Cmr) Cas proteins. The
psiRNA-Cmr protein complexes cleave complemen-
tary target RNAs at a fixed distance from the 30 end
of the integral psiRNAs. InPyrococcus furiosus, psiR-
NAs occur in two size forms that share a common 50
sequence tag but have distinct 30 ends that direct
cleavage of a given target RNA at two distinct sites.
Our results indicate that prokaryotes possess a
unique RNA silencing system that functions by
homology-dependent cleavage of invader RNAs.
INTRODUCTION
RNAs that arise from the clustered regularly interspaced short
palindromic repeats (CRISPRs) found in prokaryotic genomes
are hypothesized to guide proteins encoded by CRISPR-associ-
ated (cas) genes to silence potential genome invaders in prokary-
otes (Makarova et al., 2006). CRISPRs consist of multiple copies
of a short repeat sequence (typically 25 - 40 nucleotides) sepa-
rated by similarly-sized variable sequences that are derived
from invaders such as viruses and conjugative plasmids (Mojica
et al., 2005; Pourcel et al., 2005; Godde and Bickerton, 2006;
Lillestol et al., 2006; Makarova et al., 2006; Sorek et al., 2008;
Tyson and Banfield, 2008). CRISPR loci are found in nearly all
sequenced archaeal genomes and approximately half of bacte-
rial genomes (Haft et al., 2005; Godde and Bickerton, 2006;Makarova et al., 2006). cas genes are strictly found in the
genomes of prokaryotes that possess CRISPRs, frequently in
operons in close proximity to the CRISPR loci (Jansen et al.,
2002; Haft et al., 2005; Makarova et al., 2006). Over 40 cas genes
have been described, a subset of which is found in any given
organism (Jansen et al., 2002; Haft et al., 2005; Makarova et al.,
2006). The proteins encoded by the cas genes include predicted
RNA binding proteins, endo- and exo-nucleases, helicases, and
polymerases (Jansen et al., 2002; Haft et al., 2005; Makarova
et al., 2006). Recent studies have demonstrated that CRISPRs
and cas genes function in invader defense in prokaryotes. Expo-
sure of microorganisms that possess the CRISPR-Cas system to
a virus results in the appearance of new virus-derived sequences
at the leader-proximal end of CRISPR loci in the genomes of
surviving individuals (Barrangou et al., 2007; Deveau et al.,
2008). Moreover, the acquisition or loss of invader-specific
CRISPR elements or of Cas protein genes has been directly
correlated with virus and plasmid resistance or sensitivity,
respectively (Barrangou et al., 2007; Brouns et al., 2008; Deveau
et al., 2008). This rapidly evolving immune system influences the
ecology of natural microbial populations (Andersson and Ban-
field, 2008; Tyson and Banfield, 2008; Heidelberg et al., 2009).
RNAs from the CRISPR loci are hypothesized to guide the
CRISPR-Cas defense response based on their potential to
base pair with invading nucleic acids. Available data indicate
that entire CRISPR loci are transcribed from the leader region,
producing primary transcripts containing the full set of CRISPR
repeats and embedded invader-derived (or guide) sequences
(Jansen et al., 2002; Tang et al., 2002, 2005; Lillestol et al.,
2006, 2009; Hale et al., 2008). These large precursor RNAs are
processed into shorter (60–70 nucleotide) intermediate RNAs
that contain individual invader-targeting sequences (25–40
nucleotides) by Cas endonucleases that cleave within the
repeats (Brouns et al., 2008; Carte et al., 2008). However, the
ultimate products of the CRISPR loci appear to be smaller
RNAs (Brouns et al., 2008; Hale et al., 2008; Lillestol et al.,
2009). In Pyrococcus furiosus, themost abundant CRISPR RNAs
are two species of 45 nucleotides and 39 nucleotides (Hale
et al., 2008). These small, abundant products of the CRISPR
loci are thought to be the prokaryotic silencing (psi)RNAs of the
CRISPR-Cas RNA silencing pathway (Makarova et al., 2006;
Brouns et al., 2008; Hale et al., 2008).Cell 139, 945–956, November 25, 2009 ª2009 Elsevier Inc. 945
Figure 1. Identification of a Ribonucleoprotein Complex Containing psiRNAs and Cas Proteins
(A) psiRNP purification scheme. Letters indicate the location of corresponding data within Figure 1.
(B) psiRNA (Northern panel) and total RNA (SYBR panel) profiles across the initial Q-sepharose anion exchange fractions and an unfractionated sample (total).
Northern analysis (top panel) was performed for P. furiosus psiRNA 7.01. The positions of the mature psiRNAs and 1X intermediate RNA (Hale et al., 2008) are
indicated. The SYBR panel shows all RNAs detected by SYBR Gold staining. The peak fraction is indicated by an arrow in each panel. Noncontiguous lanes from
the same gel (total sample) and a second gel (fractions 24–30) are indicated by dashed lines.
(C) psiRNA (Northern analysis of psiRNA 7.01) and total RNA (SYBR staining) profiles across the S-sepharose cation exchange fractions and starting material
(load). The peak fraction is indicated by an arrow in each panel. Noncontiguous lanes from the same gel are indicated by dashed lines.
(D) Native gel Northern analysis of the psiRNP. The peak S-sepharose fraction (arrow, [C]) was fractionated by native gel electrophoresis and analyzed by
Northern blotting for psiRNA 7.01. RNA extracted from the same fraction was coanalyzed. The position of the psiRNP is indicated.
(E) Cas proteins identified by tandem mass spectrometry. The isolated psiRNP (D) was subject to in-gel trypsin digestion and tandem mass spectrometry.
Sequence coverage and the number of unique peptides for Cas proteins identified with 99% confidence are shown. P. furiosus cas gene names are as given
(Haft et al., 2005) and proposed functions are as predicted (Haft et al., 2005; Makarova et al., 2006). See also Table S1.946 Cell 139, 945–956, November 25, 2009 ª2009 Elsevier Inc.
Intriguingly, the protein-mediated functions of the CRISPR-
Cas system are apparently carried out by distinct sets of Cas
proteins in different organisms (Haft et al., 2005). Six ‘‘core’’
CRISPR-associated genes (cas1 - cas 6) are found in many
and diverse organisms, however, most organisms have only
a subset of these 6 genes and only cas1 is present in nearly all
organisms that appear to possess the system (Haft et al.,
2005; Makarova et al., 2006). Furthermore, the core cas genes
in a given organism are complemented by one or more sets of
additional cas genes: the cse, csy, csn, csd, cst, csh, csa, csm,
and cmr genes (Haft et al., 2005). These sets are comprised of
2 to 6 CRISPR-associated genes that cosegregate, and are
mostly designated for a prototypical organism (e.g., the cse or
Cas subtype Escherichia coli genes) (Haft et al., 2005). (The
cmr (Cas module RAMP) gene set is named for its 4 RAMP
(repeat-associated mysterious proteins; see below) gene
members.) E. coli K12, for example, has 3 core cas genes and
the full set of 5 cse genes (which includes the E. coli subtype
member of the core Cas5 gene family, cas5e) (Brouns et al.,
2008). Phylogenetic analyses suggest that the cas genes are
distributed by lateral gene transfer (Jansen et al., 2002; Makar-
ova et al., 2002; Haft et al., 2005). The functional consequences
of the differences in the complement of Cas proteins found
among organisms are not yet known.
Functional classes have been predicted for many of the Cas
proteins based on sequence, but very few of the proteins have
been characterized. Only one of the core Cas proteins, Cas6,
has a clearly established function which is to process precursor
CRISPR RNAs to release individual invader-targeting RNAs
(Carteet al., 2008).Cas1was recently shown tobeaDNA-specific
endonucleasewith properties consistentwith a role in processing
invader DNA into fragments that become incorporated into
CRISPR loci (Wiedenheft et al., 2009). The five E. coli subtype
Cas proteins (Cse1-4 and Cas5e (Haft et al., 2005)) have been
shown to form a complex that processes precursor CRISPR
RNAs in E. coli (which lacks Cas6) (Brouns et al., 2008). Many of
the Cas proteins are members of the large superfamily of RAMP
proteins, which have features of RNA binding proteins (Makarova
et al., 2002; Haft et al., 2005;Makarova et al., 2006). At least a few
of the RAMPs (including for example Cas6) have been found to
possess previously unpredicted nuclease activity (Beloglazova
et al., 2008; Brouns et al., 2008; Carte et al., 2008). The Cas
proteins are expected to function in various aspects of mainte-
nance of CRISPR gene loci (including addition of new invader-
derived elements in response to infection) as well as psiRNA
biogenesis and psiRNA-mediated resistance to invaders.
While there is very strong evidence that CRISPR RNAs and
Cas proteins function to silence potential invaders in prokaryotes
(Barrangou et al., 2007; Brouns et al., 2008; Deveau et al., 2008),
the effector complexes and silencing mechanisms of the
CRISPR-Cas pathway remain unknown. Recent studies in
Staphylococcus species and E. coli (Brouns et al., 2008; Marraf-
fini and Sontheimer, 2008) indicate that the CRISPR-Cas
systems present in those organisms (comprised of the Csm orCse proteins and several core Cas proteins, respectively) target
invader DNA rather than RNA, but the effectors andmechanisms
of silencing in these organisms remain unknown. The results
presented here demonstrate that the Cmr or RAMP module
proteins function with mature psiRNAs to cleave target RNAs.
These findings define psiRNA-guided RNA cleavage as a mech-
anism for the function of the CRISPR-Cas system in organisms
that possess the RAMP module of Cas proteins.
RESULTS
Isolation of a Complex Containing Mature psiRNAs
and a Subset of Cas Proteins
PsiRNAs are hypothesized to guide Cas proteins to effect
invader silencing in prokaryotes (Makarova et al., 2006; Brouns
et al., 2008; Hale et al., 2008). P. furiosus is a hyperthermophilic
archaeon whose genome encodes 200 potential psiRNAs (orga-
nized in seven CRISPR loci) and at least 29 potential Cas
proteins (largely found in 2 gene clusters), including members
of all six core Cas protein families and three sets of additional
Cas proteins: the Cmr, Cst and Csa proteins (see Figure 1F). In
P. furiosus, most psiRNAs are processed into two species of
45 nucleotides and 39 nucleotides (Hale et al., 2008). To
gain insight into the functional components of the CRISPR-Cas
invader defense pathway, we isolated complexes containing
the mature psiRNA species from P. furiosus cellular extract on
the basis of psiRNA fractionation profiles (Figure 1). The doublet
of psiRNAs, detectable both by Northern blotting of an individual
psiRNA and total RNA staining (SYBR), was purified away from
larger CRISPR-derived RNAs (including the 13 intermediate;
Hale, 2008) as well as other cellular RNAs (Figure 1C).
To determine whether the psiRNAs are components of RNA-
protein complexes in the purified fraction (Figure 1C), we per-
formed native gel northern analysis. The mobility of the psiRNAs
on native gel electrophoresis was reduced in the purified fraction
relative to a sample from which proteins were extracted (Fig-
ure 1D), indicating the presence of psiRNA-protein complexes
in the purified fraction. We gel purified the psiRNA-containing
complex from the native gel and analyzed the sample by mass
spectrometry. The sample contained a mixture of proteins
that included seven Cas proteins identified with 99% confi-
dence: Cmr1-1, Cmr1-2, Cmr2, Cmr3, Cmr4, Cmr5, and Cmr6
(Figure 1E).
The identities of the non-Cas proteins found in the sample are
listed in Table S1, available online. Analysis of a native gel-purified
psiRNPobtainedbyanalternatechromatographyschemerevealed
asimilarCasproteinprofile (Cmr2,Cmr3,Cmr4, andCmr6), but few
common non-Cas proteins (Table S1). The five common copurify-
ing non-Cas proteins are denoted in Table S1. None of these
proteins has any known link to the CRISPR-Cas system.
Remarkably, the seven Cas proteins associated with the
complex are all encoded by the tightly linked RAMP module or
cmr genes (Haft et al., 2005). Moreover, the identified proteins
comprise the complete set of Cmr proteins (Haft et al., 2005).(F) Genome organization of predicted P. furiosus cas genes. Operon organization andCOG assignmentswere adapted fromNCBI database. Core cas genes (cas)
and Cas module-RAMP (cmr), Cas subtype Apern (csa) and Cas subtype Tneap (cst) genes are indicated. Proteins identified by mass spectrometry are indicated
in black.Cell 139, 945–956, November 25, 2009 ª2009 Elsevier Inc. 947
Figure 2. psiRNA Species in the RNP
Contain a Common 50 Sequence Element
and Distinct 30 Termini
(A) Sequence analysis of RNAs associated with
the complex. RNA species present in the S-
sepharose fraction (visualized by SYBR Gold
staining) are shown in SYBR panel. RNAs in the
upper and lower bands were isolated, cloned,
and sequenced. Graphs show the percentage of
sequenced RNAs with 50 ends located at specific
positions within the repeat sequence (black),
and with indicated numbers of guide sequence
nucleotides downstream of the repeat sequence
(orange). The average guide sequence is 37 nucle-
otides in P. furiosus. A consensus for each psiRNA
species is diagrammed under each graph. The
8-nucleotide repeat sequence found at the 50
end of the majority of the psiRNAs is indicated as
the psi-tag. See Table S2 for sequences of the
cloned psiRNAs.
(B) Model for biogenesis of the two psiRNA
species in P. furiosus. CRISPR locus transcripts
containing alternating repeat (R, black segments)
and guide (G, colored segments) elements are
cleaved at a specific site within the repeat by the
Cas6 endoribonuclease (Carte et al., 2008), ulti-
mately producing 1X intermediate RNAs that
contain a full invader-targeting sequence flanked
on both sides by segments of the repeat. The
mature RNAs retain the 50 end repeat sequence
(psi-tag). Uncharacterized 30 end processing of
the 1X intermediate by endo- and/or exo-nucle-
ases forms the two major mature psiRNAs: a 45-
nucleotide species that contains the 8-nucleotide
psi-tag and a full guide sequence, and a 39-nucle-
otide species that contains a shorter 31-nucleo-
tide guide sequence.
(C) Deep sequencing of small RNAs from P. furio-
sus confirms the presence of the psi-tag. The 50
ends of the sequenced psiRNAs are graphed as
in (A). The number of total clones analyzed (n) is
indicated in the graphs of panels (A) and (C).(The independently defined ‘‘polymerase cassette’’ is closely
related to the RAMP module (Makarova et al., 2006).) There are
6 cmr genes: cmr2 encodes a predicted polymerase with HD
nuclease domains, and cmr1, cmr3, cmr4, and cmr6 encode
repeat-associated mysterious proteins (RAMPs) (Makarova
et al., 2002; Haft et al., 2005). The P. furiosus genome contains
two cmr1 genes and a single representative of each cmr2 –
cmr6, and all seven corresponding proteins were found in the
purified psiRNP complex (Figure 1E). The organization of the
genes encoding the seven identified proteins is shown in Fig-
ure 1F. Six of the seven identified Cas proteins are encoded in
a nearly contiguous region of one of the two major cas gene
loci in P. furiosus. This locus is located directly adjacent to
CRISPR locus 7, and also encodes core Cas proteins Cas1 -
Cas4, Cas5t, and Cas6. The striking correlation between the
evolutionary cosegregation and physical association of the
6 Cmr proteins strongly supports the cofunction of the proteins.
Our findings indicate that the two mature psiRNA species are
components of complexes containing the RAMP module or
Cmr proteins in P. furiosus.948 Cell 139, 945–956, November 25, 2009 ª2009 Elsevier Inc.psiRNAs Possess a 50 psiRNA-Tag Sequence
In order to better understand the nature of the two psiRNA
species that are components of the purified complexes, each
of the two RNA bands present in the final chromatography
sample (Figure 2A) was extracted and cloned. We obtained
sequences of 51 RNAs (20 from the upper band and 31 from
the lower band) that included psiRNAs from all seven P. furiosus
CRISPR loci (Table S2). Six RNAs with the same guide sequence
were represented in both the upper and lower bands, consistent
with Northern analysis that has shown that most psiRNAs exist in
both size forms (Hale et al., 2008).
The cloned psiRNAs consisted primarily of an individual guide
(invader-targeting or ‘‘spacer’’) sequence, however, all of the
clones retained a portion of the common repeat sequence at
the 50 end. Indeed, the majority (70%) of the RNAs in both
bands contained an identical 50 end consisting of an 8-nucleo-
tide segment of the repeat sequence (Figure 2A). The difference
between the two psiRNA size forms was found at the 30 ends.
Downstream of the repeat sequence, the majority of the clones
from the top band contained 37 nucleotides of guide sequence
(the full length of a typical guide element inP. furiosus) (Figure 2A,
top panel). The 30 ends of most of the clones from the bottom
band were located within the guide sequence. The majority of
these RNAs contained 31 nucleotides of guide sequence down-
stream of the repeat sequence (Figure 2A, bottom panel).
The psiRNAs are processed from long CRISPR locus tran-
scripts (Tang et al., 2002, 2005; Lillestol et al., 2006; Brouns et al.,
2008; Hale et al., 2008; Lillestol et al., 2009) (Figure 2B). In P. fur-
iosus, the Cas6 endoribonuclease cleaves CRISPR RNAs at a
site within the repeat element located 8 nucleotides upstream
of the guide sequence, generating the precise 50 end observed
in the two psiRNA species found in the complex (Figure 2B; Carte
et al., 2008). Our results indicate that the 50 end generated by the
Cas6 endoribonuclease is maintained in the mature psiRNAs, but
that theRNAsundergo further processingat the 30 end togenerate
psiRNAs that contain either 37 or 31 nucleotides of guide
sequence (Figure2B). Themechanism thatdefines the twodistinct
30 endboundaries is not known. The larger45-nucleotidemature
psiRNA species is generally more abundant than the smaller
39-nucleotide species (Hale et al., 2008; Figures 1 and 2A).
The short repeat sequence that remains at the 50 end ofmature
psiRNAs in P. furiosus provides a common identifying sequence
tag for the psiRNAs that could function in recognition of the RNAs
by the proteins in the CRISPR-Cas pathway. In order to more
rigorously delineate the potentially important psiRNA-tag or ‘‘psi-
tag,’’ we purified small RNAs from P. furiosus, performed deep
sequencing and obtained the sequences of the 50 ends of more
than 10,000 CRISPR-derived RNAs (from loci 1-7). The 50 ends
of the majority of the RNAs mapped 8 nucleotides upstream of
the guide sequence (Figure 2C), verifying the presence of
a discrete psi-tag on small CRISPR-derived RNAs in P. furiosus.
The sequences of CRISPR repeats (from which psi-tags are
derived) are generally conserved within groups of organisms,
but can vary widely (Godde and Bickerton, 2006; Kunin et al.,
2007). Thus, while the sequence of the psi-tag found on most
P. furiosus psiRNAs (AUUGAAAG) can be found in the repeat
sequence of numerous organisms, psi-tags of distinct sequence
and length would be expected in others. We found evidence to
support this prediction in the psiRNAs from P. furiosus CRISPR
locus 8, which contains a single nucleotide deletion in the
psi-tag region of the repeat. The majority (60%) of the 640
sequenced RNAs that mapped to CRISPR locus 8 possessed
a 7-nucleotide AUUGAAG psi-tag. In E. coli, CRISPR transcripts
are cleaved by a different endoribonuclease (Cse3 of the Cse
complex), which nonetheless appears to generate RNAs with an
8-nucleotide AUAAACCG repeat sequence at the 50 end (Brouns
etal., 2008). An8-nucleotideACGAGAACrepeat sequence isalso
present at the 50 termini of CRISPR RNAs in S. epidermidis
(Marraffini and Sontheimer, 2008), suggesting that the psi-tag
is a general feature of the psiRNAs. Interestingly, the distinct
CRISPR repeat sequences found in various genomes are accom-
panied by distinct subsets of Cas proteins (Kunin et al., 2007),
which may reflect coupling of specific series of Cas proteins
with the psi-tagged RNAs that they recognize.
Homology-Dependent Cleavage of a Target RNA
One hypothesis for the mechanism by which CRISPR RNAs
and Cas proteins mediate genome defense is psiRNA-guidedcleavage of invader nucleic acids (Makarova et al., 2006). There-
fore, we tested the ability of the isolated psiRNP complexes to
recognize andcleave a labeledRNAandDNA target complemen-
tary to endogenous P. furiosus psiRNA 7.01 (first psiRNA en-
coded in CRISPR locus 7, which Northern analysis indicated is
present in the native complexes, see Figure 1). The 50 end-labeled
7.01 target RNA was cleaved at two sites (site 1 indicated with
green vertical line and site 2 indicated with blue vertical line,
substrate 1, Figure 3B) yielding 50 end-labeled products of 27 and
21 nucleotides (indicated with corresponding green and blue
arrowheads, substrate 1, Figure 3A). The single-stranded DNA
7.01 target sequence was not cleaved (substrate 3, Figure 3).
Further characterization of the cleavage activity revealed that
the psiRNP complexes cleave the target RNA on the 50 side of
the phosphodiester bond. The 30 end generated by the complex
is not a substrate for polyadenylation (Figure S1A), indicating the
presence of a 30 phosphate (or 20, 30 cyclic phosphate) end. In
addition, cleavage activity is lost in the presence of 0.1 mM
EDTA indicating that the enzyme depends on divalent cations
(Figure S1B). Activity was restored by the addition of 1 mM
Mg2+, Mn2+, Ca2+, Zn2+, Ni2+ or Fe2+ with no detectable change
in cleavage sites with any of the metals, but was not supported
by Co2+or Cu2+ (Figure S1B). Cleavage of the target RNA did
not require sequences extending beyond the 37-nucleotide
region of complementarity with the psiRNA, and occurred at
the same two sites in the target RNA lacking sequence exten-
sions (substrate 6, Figure 3). No activity was observed toward
RNAs that lacked homology with known P. furiosus psiRNAs,
including the reverse 7.01 target sequence, antisense 7.01 target
sequence, and a box C/D RNA (substrates 2, 7 and 8, Figure 3).
Pre-annealing a synthetic psiRNA 7.01 to the 7.01 target RNA (to
form a double-stranded RNA target) blocked cleavage by the
psiRNPs (substrate 5, Figure 3). Finally, we tested a target for
endogenous P. furiosus psiRNA 6.01 and observed cleavage
that generates 2 products of the same sizes observed for the
7.01 target RNA (substrate 4, Figure 3).
These results demonstrate the presence of cleavage activity in
P. furiosus that is specific for single-stranded RNAs that are
complementary to psiRNAs. The activity is associated with
a purified fraction that contains 2 mature psiRNA species and
7 RAMP module (Cmr) proteins.
Cleavage of the Target RNA Occurs a Fixed Distance
from the 30 End of the psiRNA
To investigate the mechanism of psiRNA-directed RNA
cleavage, we analyzed the results of cleavage assays with a
series of truncations of the 7.01 target RNA (Figure 4A). We found
that the target RNA truncations analyzed did not affect the loca-
tions of the two cleavage sites. The full-length 7.01 target RNA is
cleaved at sites 1 and 2 to generate 14- and 20-nucleotide 50
end-labeled products, respectively (Figures 3 and 4A). The 30
end-truncated target RNAs were cleaved at the same two sites
to yield the same two 50 end-labeled cleavage products (except
where truncation eliminated cleavage site 2, D20–37, Figure 4A).
On the other hand, in the case of the 50 end-truncated target
RNAs, cleavage at the same sites would be expected to
generate shorter 50 end-labeled cleavage products. The 14-
nucleotide product that results from cleavage of the D1-6 targetCell 139, 945–956, November 25, 2009 ª2009 Elsevier Inc. 949
Figure 3. Specific Cleavage of Complementary Target RNAs
The indicated 50 end-labeled substrates were incubated in the presence (+) or absence () of the native psiRNPs (Figure 1C). Products were resolved by dena-
turing gel electrophoresis. The primary cleavage products are indicated by green and blue arrows in panel A, and the corresponding sites of cleavage are indi-
cated with green (site 1) and blue (site 2) vertical lines in the substrate sequences shown in panel (B). Noncontiguous lanes from the same gel are indicated by
dashed lines, and the sizes of RNAmarkers (M) are indicated in panel A. ‘‘Target’’ substrates (1, 3, 4, 5, 6) contain regions of perfect complementarity to the guide
sequence of the indicated P. furiosus psiRNA. Grey bars demarcate the guide sequences in the panel B. ‘‘+ ext’’ substrates (1, 2, 3, 4, 5) contain 50 and 30 polyA
extensions. For substrate 5, a synthetic psiRNA (sequence shown in gray) was pre-annealed to the 7.01 target RNA + ext. Substrate 2 is a reverse target sequence
substrate and substrate 7 is an antisense target substrate. Substrate 3 is DNA; all other substrates are RNA. Substrate 8 is unrelated RNA sR2. See Figure S1 for
further characterization of the cleavage activity.RNA at site 2 was observed (Figure 4A), but cleavage at site
1 could not be assessed because the size of the product is below
that which could be detected in the experiment. If the twelve-
and eighteen-nucleotide 50 end-truncated target RNAs were
cleaved at the same two sites, the products would also be
outside the range of detection, however, interestingly, very little
cleavage of these RNAs was observed (Figure 4, D1–18 and D1–
12, compare substrate band +/ complex).
Strikingly, the difference in the sizes of the two cleavage prod-
ucts observed with the various substrates is the same as the
difference in the sizes of the two endogenous psiRNA species
(6 nucleotides in both cases, Figure 3). This size difference as
well as the specific product sizes suggest that the two cleavages
occur a fixed distance (14 nucleotides) from the 30 ends of the
two psiRNAs. Figure 4B illustrates the proposed mechanism
by which the 45- and 39-nucleotide psiRNAs guide cleavage at950 Cell 139, 945–956, November 25, 2009 ª2009 Elsevier Inc.target sites 1 and 2, respectively, for each of the target RNAs
analyzed here. For example, using the full-length 7.01 target
RNA we observed 20- and 14-nucleotide cleavage products
(Figure 3, panel 5) suggesting cleavage of the bound target
RNA 14 nucleotides from the 30 end of the 39- and 45-nucleotide
psiRNAs, respectively (Figure 4B, F.L.). In addition, a 7-nucleo-
tide extension at the 50 end of the target RNA resulted in a pair
of 50 end-labeled products 27 and 21 nucleotides in length
(Figure 3A), consistent with cleavage of the substrate 14 nucleo-
tides from the ends of the two psiRNAs (Figure 4B, F.L.+ext). The
anchor for this counting mechanism is the 30 end of the psiRNA.
While reductions in the extent of duplex formation between the 50
end of the psiRNA and the cleavage site (30 truncations to within
6 nucleotides of the cleavage site) did not have an observable
effect on cleavage efficiency, truncations that reduced duplex
formation between the 30 end of the psiRNA and the cleavage
Figure 4. Cleavage Occurs 14 Nucleotides from the 30 Ends of the psiRNAs
(A) The indicated 50 end-labeled (*) substrates were incubated in the presence (+) or absence () of the psiRNP (Figure 1C). The substrates were full-length 7.01
target RNA (F.L.), and the indicated truncations, and are diagramed below the gel. As in Figure 3, the locations of observed cleavages at sites 1 (green) and 2 (blue)
are indicated on the diagrams of the substrate RNAs and the corresponding cleavage products are indicated with green and blue arrows on the gel. The question
mark on the diagram of the D1-6 target RNA indicates that this cleavage could not be assessed. Noncontiguous lanes from the same gel are indicated by dashed
lines.
(B) Model for cleavage at two sites directed by two psiRNAs. The 45-nucleotide psiRNA species guides cleavage at site 1 and the 39 nucleotide psiRNA guides
cleavage at site 2 on each of the substrate RNAs as indicated. In both cases, cleavage occurs 14 nucleotides from the 30 end of the psiRNA. Observed products
are shown in green (site 1) and blue (site 2) and correspond to products in Figures 3 and 4A.site had a strong negative impact, suggesting that basepairing of
the last 14 nucleotides of the psiRNA with the target is critical for
cleavage activity.
The results of these studies indicate that both of the mature
psiRNA species are active in guiding target RNA cleavage by
a mechanism that depends upon the distance from the 30 end
of the psiRNA.
Analysis of Reconstituted Cmr-psiRNA Complexes
Identification of the Cmr proteins in the purified psiRNP complex
(Figure 1) along with the evolutionary evidence for their cofunc-
tion with the CRISPRs (Jansen et al., 2002; Makarova et al.,
2002; Haft et al., 2005) strongly suggests that the Cmr proteins
and psiRNAs function as a complex to cleave target RNAs
(Figure 3). In order to determine whether the Cmr proteins and
psiRNAs are sufficient for function (independent of other copur-
ifying P. furiosus components), we tested the ability of purified
recombinant Cmr proteins and synthetic psiRNAs to cleave
target RNAs (Figure 5). A reconstituted set of six P. furiosus
Cmr proteins (Cmr1-1, Cmr2 – Cmr6) and two mature psiRNA
species (45- and 39-nucleotide psiRNA 7.01, found in the native
complex based on Northern analysis [Figure 1] and activity of the
native complex against the 7.01 target [Figure 3]) cleaved the
target RNA at 2 sites generating the same size products as those
observed with the isolated native complex (Figure 5A). While
both P. furiosus isoforms of the Cmr1 protein are present in theisolated complexes (Figure 1), we found that only one of the
two proteins (Cmr1-1) was required for a functional reconstituted
complex (Figure 5A), suggesting that the isoforms may perform
redundant functions. No activity was observed in the absence
of the psiRNAs or in the absence of the Cmr proteins (Figure 5A),
indicating that both are necessary. These results demonstrate
that the RAMP module Cas proteins and psiRNAs function
together to cleave complementary target RNAs.
In order to determine whether all of the six Cmr proteins are
essential for psiRNA-guided RNA cleavage, we assayed
cleavage activity in the absence of each of the individual proteins
(Figure 5B). Omission of Cmr5 did not observably affect the
activity of the complex (Figure 5B). However, cleavage was
significantly reduced in the absence of any one of the other
proteins (Figure 5B), indicating that 5 of the 6 RAMP module
proteins are required for activity of the psiRNA-Cmr protein
complex.
Finally, we had reconstituted the cleavage activity profile
observed for the native complexes using the two psiRNA species
(45- and 39-nucleotides) (e.g., Figure 5A). Our model for the
mechanismof cleavage predicts that each of the psiRNAs guides
a distinct cleavage: the 45-nucleotide psiRNA at site 1, and the
39-nucleotide psiRNA at site 2 (see Figure 4B). To determine
whether both psiRNAs are required for activity, and whether
each guides the distinct cleavage that is predicted by the model,
we tested the activity of complexes reconstituted with a singleCell 139, 945–956, November 25, 2009 ª2009 Elsevier Inc. 951
Figure 5. Target RNA Cleavage Requires Five Cmr Proteins and a Single psiRNA Species
(A) 50 end-labeled 7.01 target RNA was incubated in the absence of added psiRNAs or proteins (), in the presence of synthetic psiRNAs (+) or purified recombi-
nant P. furiosus Cmr proteins (R), or in the presence of purified native psiRNPs (N) as indicated. The synthetic psiRNAs were 45- and 39-nucleotide forms of
psiRNA 7.01. The six added recombinant Cmr proteins were P. furiosus Cmr1-1, Cmr2, Cmr3, Cmr4, Cmr5, and Cmr6. Products were resolved by denaturing
gel electrophoresis. The products corresponding to cleavage at site 1 and site 2 (see Figure 3) are indicated by green and blue arrows, respectively. Noncon-
tiguous lanes from the same gel are indicated by a dashed line. The sizes of RNA markers (M) are indicated.
(B) The 7.01 target RNA (Target) was incubated with the synthetic 7.01 psiRNAs (both 45- and 39-nucleotide species) in the absence (+ psiRNAs) and presence of
the purified recombinant P. furiosus Cmr proteins (all), and also with combinations of proteins lacking individual Cmr proteins as indicated (e.g., - Cmr6).
(C) Cleavage activity of the recombinant psiRNP (R) reconstituted with either the individual 7.01 psiRNA species (45- or 39-nt) or both. Cleavage by the native
psiRNP (N) is included for comparison.psiRNA. As predicted, we found that the 45-nucleotide psiRNA
guided cleavage at site 1 producing a 14-nucleotide 50 end-
labeled product, and the 39-nucleotide psiRNA guided cleavage
at site 2 producing a 20-nucleotide 50 end-labeled product (Fig-
ure 5C). Based on our truncation analysis (Figure 4, D20-37),
the larger product of the cleavage guided by the 39-nucleotide
psiRNA could act as a substrate for cleavage guided by the
45-nucleotide psiRNA, and consistent with this, we often obtain
more of the smaller cleavage product in cleavage assays where
both guide RNAs are present with either the native complex or
the reconstituted complex (e.g., Figure 5A). The results of these
experiments demonstrate that each of the psiRNA species is
competent to form functional psiRNPs and guides cleavage 14
nucleotides from its 30 end.
DISCUSSION
The findings presented here reveal the mechanism of action of
an RNA-protein complex implicated in a novel RNA silencing
pathway that functions in invader defense in prokaryotes.
Previous work had shown that both invader-specific sequences952 Cell 139, 945–956, November 25, 2009 ª2009 Elsevier Inc.within CRISPRs and Cas protein genes are important in virus
and plasmid resistance in prokaryotes (Barrangou et al., 2007;
Brouns et al., 2008; Deveau et al., 2008; Marraffini and Son-
theimer, 2008). The results presented here establish how small
RNAs from CRISPRs and the RAMP module Cas proteins func-
tion together to destroy RNAs recognized by the CRISPR RNAs.
The major findings and models established in this work are
summarized in Figure 6.
Our findings indicate that the RAMP module of the CRISPR-
Cas system silences invaders by psiRNA-guided cleavage of
invader RNAs (Figure 6). Specifically, the results indicate that
psiRNAs present in complexes with the Cmr proteins recognize
and bind an invader RNA such as a viral mRNA (via the psiRNA
guide sequence co-opted from the invader by another branch
of the CRISPR-Cas system), and that the complex then cleaves
the invader RNA, destroying the message and presumably
blocking the viral life cycle. The psiRNA-Cmr complexes cleave
complementary RNAs (Figures 3 and 5). Five of the six Cmr
proteins are required for target RNA cleavage (Figure 5) and
the component of the complex that provides catalytic activity
remains to be determined. Cmr2 contains a predicted nuclease
Figure 6. Model for the Function of psiRNA-Cmr Protein Complexes in Silencing Molecular Invaders
Based on the results of this study, a psiRNA with a conserved 50 sequence element derived from the CRISPR repeat (psi-tag) and a region of invader-targeting
sequence assembles with six Cas module-RAMP proteins (Cmr1–6). The assembled psiRNP interacts with an invader RNA (e.g., viral mRNA) through base pair-
ing between the psiRNA and invader RNA, positioning the region of the RNA-RNA duplex 14 nucleotides from the 30 end of the psiRNA in proximity to the active
site (star) of the enzyme. In P. furiosus, there are two prominent size forms of each psiRNAwith different 30 ends that guide cleavage of viral mRNAs at two distinct
sites. There are also two Cmr1 proteins in P. furiosus that are both found in purified preparations and likely function redundantly.domain (Makarova et al., 2002, 2006), however the other four
essential proteins (Cmr1, 3, 4 and 6) belong to the RAMP super-
family, members of which have been found to be ribonucleases
(Beloglazova et al., 2008; Brouns et al., 2008; Carte et al., 2008).
It will be important in future work to identify the catalytic compo-
nent(s) of the psiRNA-Cmr protein complex. Our data indicate
that the Cmr ribonuclease generates products with 30 phosphate
(or 20, 30 cyclic phosphate) and 50 hydroxy termini and requires
divalent metal ions for activity (Figure S1).
Our results also establish a simplemodel for themechanism of
cleavage site selection by the psiRNA-Cmr effector complex -
a 14-nucleotide ruler anchored by the 30 end of the psiRNA
(Figure 6). We found that P. furiosus psiRNAs occur in two
lengths that share a 50 psi-tag (derived from the CRISPR repeat)
and contain either 37 or 31 nucleotides of guide sequence
(Figures 1 and 2). Both psiRNA species are associated with
the Cmr effector complex (Figure 1) and each guides cleavage
at a distinct site (Figure 5C). Analysis of the cleavage products
of both psiRNAs and of a series of substrate RNAs (Figures 3,
4, and 5) indicates that the complex cleaves based on a 14-
nucleotide counting mechanism anchored by the 30 end of
the psiRNA. The results suggest that the 30 end of the psiRNA
places the bound target RNA relative to the enzyme active site
(Figure 6).
The activity of the psiRNA-Cmr protein complex (RNA-guided
RNA cleavage) bears an interesting resemblance to that of Argo-
naute 2 (a.k.a. Slicer) (Liu et al., 2004), an enzyme with an analo-
gous function in the eukaryotic RNAi pathway, however there is
little similarity between the enzymes. There is no significant
sequence homology between the Cmr proteins and Argonaute
2 (or between any of the Cas proteins and known components
of the eukaryotic RNAi pathway). Both the psiRNA-Cmr complex
and Argonaute 2 employ a ruler mechanism for cleavage siteselection; however, in the case of Argonaute 2, the site of
cleavage is located 10-11 nucleotides from the 50 end of the
siRNA (Elbashir et al., 2001a, 2001b). The activity of both
enzymes requires divalent metal ions (Figure S1 and (Schwarz
et al., 2004)), however for the psiRNA-Cmr RNP, it is not yet clear
whether the metal is involved in cleavage catalysis or is required
for some other essential aspect of the functionality of this multi-
component complex. Finally, Argonaute 2 cleaves target RNAs
on the 30 side of the phosphodiester bond, leaving 30 OH and
50 phosphate termini (Martinez and Tuschl, 2004). It is interesting
that eukaryotes and prokaryotes exploit distinct small RNA-
guided gene silencing pathways to combat viruses and other
mobile genetic elements that they encounter (Ghildiyal and
Zamore, 2009; Malone and Hannon, 2009).
Figure6also illustrates theCmr-psiRNAeffectorcomplexmodel
that arises from the findings presented here. Both size classes of
psiRNAs and all seven Cmr proteins are found in complexes in
active, purified fractions (Figure 1), however accurateRNA-guided
cleavage activity can be reconstituted with either psiRNA species
and with a single Cmr1 isoform (Figure 5). We hypothesize that
each psiRNA associates with a single set of six Cmr proteins,
and that Cmr1-1 and Cmr1-2 function redundantly in P. furiosus.
Five unrelated proteins that copurified with the complexes (Table
S1) are not essential for reconstitution of cleavage activity in vitro
(Figure 5) and are not included in our model, but could play
a role in function in vivo. Recognition of the psiRNAs by the Cmr
proteins and psiRNA-Cmr complex assembly likely depend
upon conserved features of the RNAs that could include 50 and
30 end groups and folded structure as well as the psi-tag. Our
data reveal that the psiRNA-Cmr complex can utilize psiRNAs of
different sizes to cleave a target RNA at distinct sites (Figure 5C).
Thus, the two size forms of psiRNAs present in P. furiosus may
provide more certain and efficient target destruction.Cell 139, 945–956, November 25, 2009 ª2009 Elsevier Inc. 953
Our data indicate that the function of the RAMPmodule of Cas
proteins is psiRNA-guided destruction of invading target RNA.
The widespread occurrence of the cmr genes in diverse archaea
(including Sulfolobus and Archaeoglobus species) and bacteria
(including Bacillus and Myxococcus species) indicates that
invader RNA cleavage is a mechanism utilized by many prokary-
otes for viral defense (Jansen et al., 2002; Haft et al., 2005;
Makarova et al., 2006). However, not all prokaryotes with the
CRISPR-Cas system possess the RAMP module (Cmr) proteins.
In these numerous other organisms, it is possible that a different
set of Cas proteins mediates psiRNA-guided RNA cleavage or
that Cas proteins effect invader resistance by another mecha-
nism. Indeed, very recent work indicates that the CRISPR-Cas
system targets invader DNA in a strain of Staphylococcus
epidermidis and perhaps E. coli (Brouns et al., 2008; Marraffini
andSontheimer, 2008), which possess theMtube (Csm) andEcoli
(Cse) subtype Cas protein modules, respectively (Jansen et al.,
2002; Haft et al., 2005; Makarova et al., 2006). The prokaryotes
include evolutionarily distant and very diverse organisms. Diver-
sity in the core components of the eukaryotic RNAi machinery
has led to a tremendous variety of observed RNA-mediated
gene silencing pathways that can act at post-transcriptional or
transcriptional levels (Chapman and Carrington, 2007; Zaratiegui
et al., 2007; Farazi et al., 2008; Hutvagner and Simard, 2008). The
diversity of Casproteins found inCRISPR-containing prokaryotes
may reflect significantly differentmechanismsofCRISPRelement
integration, CRISPR RNA biogenesis, and invader silencing.
EXPERIMENTAL PROCEDURES
Chromatography
P. furiosus S100 extract was prepared from approximately 4 g of cells. Cells
were resuspended in 20 ml of 50 mM Tris (pH 7.0), 100 U RNase-free DNase
(Promega), and 0.5 mM phenylmethanesulphonyl fluoride (PMSF) at room
temperatureby stirring. The resultingwhole-cell extractwassubject to ultracen-
trifugation at 100,000 3 g for 1.5 hr using an SW 41 Ti rotor (Beckman). The
resulting S100 extract was loaded onto a 5 ml Q-sepharose Fast Flow (GE)
pre-packed column. Proteins were eluted using a 0-1 M NaCl gradient. Frac-
tions were analyzed by Northern analysis by isolating RNA from 100 ul of each
fraction using Trizol LS (Invitrogen, following manufacturer’s instructions). The
RNAs were separated on 15% TBE-urea gels (Criterion, Bio-Rad), blotted and
analyzed for the presence of a single guide sequence as described previously
(Hale et al., 2008). Peak fractions containing the psiRNA doublet were further
separated on a second 5 ml Q-sepharose column, eluted with 220-430 mM
NaCl. Fractionswereanalyzedasdescribedabove.Peak fractionswerepooled,
diluted in 50mMsodiumphosphatebuffer, pH7.0, and loadedonto a 5ml S-se-
pharose column (GE). Boundproteinswere elutedwitha gradient of 0-1MNaCl.
Native gel northern analysiswas performed as described previously (Hale et al.,
2008). The secondary data shown in Table S1 was obtained from S100 extract
fractionated on a DEAE column as previously described (Hale et al., 2008) fol-
lowed by a hydroxyapatite column eluted with a gradient of 5–500 mM sodium
phosphate buffer (pH 6.5) and further purified by native gel electrophoresis.
Protein Assignment by Tandem Mass Spectrometry
In-gel and in-solution tryptic digests were performed as previously described
(Wells et al., 2002; Lim et al., 2008). Desalted tryptic peptides were analyzed by
nLC-MS/MS on a linear ion-trap (LTQ, ThermoFisher) as previously described
(Lim et al., 2008). Acquired data was searched against a P. furiosus-specific
database (forward and inverted) using the TurboSEQUEST algorithm (Thermo-
Fisher). Data was collated and filtered to obtain a 1% false discovery rate at the
protein level using the ProteoIQ software package (BioInquire) that is based on
the PROVALT algorithm (Weatherly et al., 2005).954 Cell 139, 945–956, November 25, 2009 ª2009 Elsevier Inc.Cloning and Sequencing of psiRNAs from the Purified Complexes
RNAs from S-column fractions (isolated as described above for Northern anal-
ysis) were treated with 1 U calf intestinal alkaline phosphatase (Promega) for
1 hr at 37C, followed by extraction with phenol:chloroform:isoamyl alcohol
(PCI; [pH 5.2], Fisher) and ethanol precipitation. The resulting RNAswere sepa-
rated by 15% polyacrylamide, TBE-urea gels (Criterion, Bio-Rad), visualized
by SYBR Gold staining (Invitrogen) and the visible bands were excised.
RNAs were passively eluted overnight in 0.5 M ammonium acetate, 0.1%
SDS, 0.5 mM EDTA, followed by ethanol precipitation. A 50-phosphorylated,
30 capped oligonucleotide (50-pCTCGAGATCTGGATCCGGG-ddC30; IDT)
was ligated with T4 RNA ligase to the 30 end of the RNAs. The ligated RNAs
were PCI extracted, ethanol precipitated, gel purified, and subject to reverse
transcription using Superscript III (Invitrogen) RT (as described by the manu-
facturer), followed by gel purification. The gel-purified cDNAs were polyA-
tailed for 15 min at 37C using terminal deoxynucleotide transferase (Roche)
using manufacturer’s recommendations. PCR was performed to amplify the
cDNA libraries using the following primers: 50-CCCGGATCCAGATCTCGAG-
30, 50-GCGAATTCTGCAG(T)30-30). cDNAs were cloned into the TOPO pCRII
(Invitrogen) cloning vector and transformed into TOP10 cells. White and
light-blue colonies were chosen for plasmid DNA preparation, and sequencing
using the M13 Reverse and T7 promoter sequencing primers was performed
by the University of Georgia Sequencing and Synthesis Facility.
Small RNA Deep Sequencing
Small RNA libraries were prepared using the Illumina small RNA Sample prep-
aration kit as described by the manufacturer (Illumina). Briefly, total RNA was
isolated from P. furiosus and fractionated on a 15% polyacrylamide/urea gel,
and small RNAs 18-65 nt in length were excised from the gel. 50 and 30 adapters
were sequentially ligated to the small RNAs and the ligation products were
gel-purified between each step. The RNAs were then reverse-transcribed
and PCR-amplified for 16 cycles. The library was purified with a QIAGEN
QuickPrep column and quantitated using an Agilent Bioanalyzer and a nano-
drop. The sample was diluted to a concentration of 2 pM and subjected to
42 cycles of sequencing on the Illumina Genome Analyzer II.
Small RNA Analysis
Sequence data was extracted from the images generated by the Illumina
Genome Analyzer II using the software applications Firecrest and Bustard.
The adaptor sequences were then trimmed from the small RNA reads, which
were then mapped to the P. furiosus genome using btbatchblast. Only reads
that mapped perfectly to the genome over their entire length were used for
further analysis. The location and number of reads that initiate within the
CRISPR repeats were determined using a perlscript. As the maximal read
length of the sequences was 42 nt, it was not possible to be certain that the
30 end of a read represented the actual 30 end of the small RNA. Therefore,
the deep sequencing data was only used to determine the 50 ends.
Nuclease Assays
To detect target RNA cleavage, 2 ml of the peak S-column fractions (Figure 1C)
or 500 nM each of recombinant proteins was incubated with 0.05 pmoles of
32P-50 end-labeled synthetic target RNAs (Figures 3, 4, and 5) and 0.5 pmoles
of each unlabeled psiRNA (Figure 5) for 1 hr at 70C in 20 mM HEPES (pH 7.0),
250 mM KCl, 1.5 mMMgCl2, 1 mM ATP, 10 mM DTT, in the presence of 1 unit
of SUPERase-In ribonuclease inhibitor (Applied Biosystems). For assays with
recombinant proteins, the psiRNAs were first incubated with the proteins for
30min at 70C prior to the addition of target RNA. Reaction products were iso-
lated by treatment with 800 ng of proteinase K for 30min at room temperature,
followed by PCI extraction and ethanol precipitation. The resulting RNAs were
separated on 15% polyacrylamide, TBE 7M urea gels and visualized by phos-
phorimaging. 50 end-labeled RNA size standards (Decade Markers, Applied
Biosystems) were used to determine the sizes of the observed products.
Annealed RNAs were prepared by mixing equimolar amounts of RNAs in
30mMHEPES (pH 7.4), 100mMpotassium acetate, 2mMmagnesium acetate
and incubating for 1 min at 95C, followed by 1 hr at 37C. Annealing was
confirmed by nondenaturing 8% PAGE.
For analysis of the chemical ends of the cleavage products, cleavage reac-
tions were performed using 50-end labeled target as described above. The
resulting RNA products were isolated by PCI extraction and ethanol precipita-
tion, and subject to polyadenylation by incubation with 5 U E. coli polyA
polymerase (NEB) for 15 min at 37C as described by the manufacturer. The
reaction was stopped by PCI extraction, followed by ethanol precipitation.
The resulting products were analyzed on 15% polyacrylamide, TBE 7M Urea
gels as described above.
In order todetermine thedivalentmetal requirementsof thepurified complex,
cleavage reactions were performed for 1 hr at 70C in 50 mM HEPES (pH 7.0),
250 mM KCl, 1 mM ATP, 10 mM DTT, 0.1 mM EDTA, and 1 mMmetal (if appli-
cable) in the presence of 1 unit of SUPERase-In ribonuclease inhibitor (Applied
Biosystems). Certified metal reference solutions (Spex CertiPrep except
calcium obtained from Fisher Scientific) were added to 1 mM final concentra-
tion. The resulting products were isolated and analyzed as described above.
Expression and Purification of Recombinant Proteins
The genes encoding P. furiosus Cmr1-1 (PF1130), Cmr2 (PF1129), Cmr3
(PF1128), Cmr4 (PF1126), Cmr5 (PF1125) and Cmr6 (PF1124) were amplified
by PCR from genomic DNA or existing constructs and cloned into a modified
version of pET24d (PF1124, PF1125, and PF1126) or pET200D (PF1128,
PF1129, and PF1130). The recombinant proteins were expressed in E. coli
BL21-RIPL cells (DE3, Stratagene). The cells (400 ml cultures) were grown to
a OD600 of 0.7, and expression of the proteins was induced with 1 mM iso-
propyl-b-D-thiogalactopyranoside (IPTG) overnight at room temperature.
The cells were pelleted, resuspended in 20 mM sodium phosphate buffer
(pH 7.6), 500 mM NaCl and 0.1 mM phenylmethylsulfonyl fluoride (PMSF),
and disrupted by sonication. The sonicated sample was centrifuged at 4,500
rpm for 15 min at 4C. The supernatant was heated at 75–78C for 20 min,
centrifuged at 4500 rpm for 20 min at 4C, and filtered (0.8 mm pore size Millex
filter unit, Millipore). The recombinant histidine-tagged proteins were purified
by batch purification using 50 ml Ni–NTA agarose beads (QIAGEN) equilibrated
with resuspension buffer. Following 3 washes (resuspension buffer), the bound
proteins were eluted with resuspension buffer containing 500 mM imidazole.
The protein samples were dialyzed at room temperature against 40 mM
HEPES (pH 7.0) and 500 mM KCl prior to performing activity assays.
Synthetic psiRNAs
The 45- and 39-nucleotide psiRNAs were chemically synthesized (Integrated
DNA Technologies). The sequence of the 45-nucleotide psiRNA 7.01 is: AUU
GAAAGUUGUAGUAUGCGGUCCUUGCGGCUGAGAGCACUUCAG. The se-
quence of the 39-nucleotide psiRNA 7.01 is: AUUGAAAGUUGUAGUAUGCG
GUCCUUGCGGCUGAGAGCA.
ACCESSION NUMBERS
Sequences of the psiRNAs are available in the Gene Expression Omnibus.
SUPPLEMENTAL DATA
Supplemental Data include two tables and one figure and can be
found with this article online at http://www.cell.com/supplemental/
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